Growth Metrics

Voyager Therapeutics (VYGR) Gains from Investment Securities (2016 - 2025)

Voyager Therapeutics (VYGR) has disclosed Gains from Investment Securities for 11 consecutive years, with -$62000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 93.75% to -$62000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.4 million through Dec 2025, down 2.6% year-over-year, with the annual reading at $9.6 million for FY2025, 9.24% up from the prior year.
  • Gains from Investment Securities hit -$62000.0 in Q4 2025 for Voyager Therapeutics, down from $926636.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $10.3 million in Q2 2025 to a low of -$2.3 million in Q4 2022.
  • Historically, Gains from Investment Securities has averaged $2.4 million across 5 years, with a median of $926636.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: soared 9991.72% in 2022 and later crashed 98.18% in 2025.
  • Year by year, Gains from Investment Securities stood at $1.4 million in 2021, then tumbled by 264.03% to -$2.3 million in 2022, then soared by 98.49% to -$35000.0 in 2023, then grew by 8.57% to -$32000.0 in 2024, then crashed by 93.75% to -$62000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for VYGR at -$62000.0 in Q4 2025, $926636.0 in Q3 2025, and $10.3 million in Q2 2025.